Arthrosamid vs. Steroid for the Management of Knee Osteoarthritis
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-100
SponsorCappagh National Orthopaedic Hospital
About this trial
This study will be a randomised control trial of the use of intra-articular Arthrosamid® a novel intraarticular hydrogel vs. standard of care (steroid and local anaesthetic) for the non-operative management of knee osteoarthritis.
Eligibility criteria
Qualifiers
Adults
Symptomatic single side knee pain.
Patients with diagnosis of knee osteoarthritis radiographic Kellgren and Lawrence system OA grade II-III-IV on x ray or MRI.
Disqualifiers
Inflammatory conditions,
Cancer,
acute infection,
pregnancy and breastfeeding.
Trial design
Treatments tested in this trial
- Arthrosamid® 2.5% iPAAG injectable implant
- Steroid Drug
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Cappagh National Orthopaedic Hospital
Lead sponsor
Contura
Collaborator
Source ClinicalTrials.gov